Waste Management (WM) Balances Healthcare Strength and Cash Flow Against Cost Pressures

Waste Management, Inc. continues to see its investment narrative shaped by third-quarter financial figures and steady capital return initiatives. While expanding profitability in healthcare operations and notable cash generation have supported the business, elevated fuel bills and weaker volumes in core collection have restrained wider profit margins.

For the period ending September 30, 2026, revenue advanced 6.3% year over year to 6.846 billion US dollars. Adjusted operating EBITDA climbed 5.8% to 2.121 billion US dollars, though the corresponding margin narrowed slightly from 31.1% to 31.0%. Gains from disposal pricing and healthcare added margin support, but an extra 40 basis points each in fuel expenses and risk-management outlays counteracted those benefits. In addition, collection and disposal volumes dropped 0.4%, which management attributed to intentional exits from lower-margin residential contracts alongside prior losses in national accounts.

In contrast, the Healthcare Solutions unit delivered clear operating momentum following the integration of Stericycle. The segment achieved a 3.7% revenue increase, while operating EBITDA expanded by more than 30% to 146 million US dollars, up from 110 million US dollars a year earlier. Operating EBITDA margins for the division hit 22.4%, aided by pricing adjustments and tighter cost controls across administrative expenses.

Cash conversion remained a primary pillar of strength. Operating cash inflows totaled 4.867 billion US dollars over the opening nine months of the year, with free cash flow rising over 42% to 3.009 billion US dollars. During the third quarter alone, the environmental services provider delivered 957 million US dollars back to investors through 580 million US dollars in share repurchases and 377 million US dollars in dividends. Management reaffirmed its intention to complete 2 billion US dollars in total buybacks across 2026.

Looking toward the end of 2026, leadership reaffirmed its full-year expectations. Total sales are projected to land near the upper boundary of the 26.275 billion to 26.475 billion US dollar target, with adjusted operating EBITDA anticipated between 8.15 billion and 8.25 billion US dollars. Free cash flow is also guided toward the top end of its 3.75 billion to 3.85 billion US dollar forecast.